David Harburger is a patent attorney working closely with life sciences clients from the early stages of formation and beyond to align their intellectual property (IP) strategy with their business goals. He advises on patent preparation and prosecution, patent portfolio management, freedom-to-operate, patent invalidity, non-infringement, IP and clinical strategy coordination, and IP due diligence matters. David has deep familiarity with patent law issues specific to life sciences-based technologies, including biochemistry, bioenergy systems, cell signaling, diagnostics, genetics, immunology, microbiome, nanoparticle carriers, nucleic acids, synthetic biology, and therapeutics. Having co-founded biotech companies, David brings an entrepreneur’s perspective to help clients build up IP as an asset while navigating a path to market. He has architected IP strategies for groundbreaking emerging technology companies to align with their entry into the public market, M&A, and partnering activities. David also advises investors in IP-related matters in financing rounds.
- U.S. and international patent strategy
- Patent portfolio management
- Life sciences
- Patent prosecution and opinions
- IP due diligence